Optimizing the Management of Menopause Symptoms:

An Overview of Guidelines for Menopause Hormone Therapy and a Review of Duavee Clinical Data

Please register to learn more about hormonal therapy in menopause. Dr. Gloria Richard-Davis will present key points from the NAMS (North American Menopause Society) hormone therapy position statement, an overview of the Women’s Health Initiative, and a review of the Duavee clinical data. The session will be moderated by Jennifer Virro, Medical Director, Women’s Health Medical Affairs at Pfizer.

We will be live streaming the same presentation across two sessions, both of which will have an opportunity for Q&A:
Monday, June 19th at 5:30-6:30 pm ET & Tuesday, June 20th at 8:30-9:30 pm ET

Meeting Agenda
Menopause Burden and Common Symptoms
Women’s Health Initiative Summary
NAMS 2022 Hormone Therapy Position Statement Key Points
Duavee Clinical Review

Jennifer Virro, MD, MBA
Medical Director
Pfizer Women’s Health

Gloria Richard-Davis, MD, MBA, NCMP, FACOG

View Bio